Status of pediatric echocardiography clinical trials: a cross-sectional study of registered trials in ClinicalTrials.gov

BackgroundThe objective of this study is to analyze the characteristics of pediatric echocardiography clinical trials registered in ClinicalTrials.gov.MethodsA data set including pediatric echocardiography clinical trials was downloaded from ClinicalTrials.gov until May 13, 2022. We searched the Pub...

Full description

Saved in:
Bibliographic Details
Main Authors: Li-Juan Mao (Author), Lan Wang (Author), Dong-Mei Lv (Author)
Format: Book
Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a1ac229d819b46f791165cb032f35981
042 |a dc 
100 1 0 |a Li-Juan Mao  |e author 
700 1 0 |a Lan Wang  |e author 
700 1 0 |a Dong-Mei Lv  |e author 
245 0 0 |a Status of pediatric echocardiography clinical trials: a cross-sectional study of registered trials in ClinicalTrials.gov 
260 |b Frontiers Media S.A.,   |c 2023-04-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2023.1167278 
520 |a BackgroundThe objective of this study is to analyze the characteristics of pediatric echocardiography clinical trials registered in ClinicalTrials.gov.MethodsA data set including pediatric echocardiography clinical trials was downloaded from ClinicalTrials.gov until May 13, 2022. We searched the PubMed, Medline, Google Scholar, and Embase databases to extract publication data. Pediatric echocardiography trial characteristics, application areas, and publication status were described. The secondary objectives were to evaluate factors associated with trial publication.ResultsWe identified 410 pediatric echocardiography reporting definite age, of which 246 were interventional and 146 were observational. Drug interventions were the most commonly studied (32.9%). The most applied area of pediatric echocardiography was congenital heart disease, followed by hemodynamics of preterm or neonatal infants, cardiomyopathy, inflammatory heart disease, pulmonary hypertension, and cardio-oncology. According to the primary completion data, 54.9% of the trials were completed before August 2020. 34.2% of the trials had been published within 24 months. Union countries and quadruple masking were more likely to be published.ConclusionEchocardiography is rapidly evolving in pediatric clinical applications, including anatomic imaging and functional imaging. Novel speckle tracking techniques have also been pivotal in the assessment of cancer therapeutics-related cardiac dysfunction. A small number of clinical trials in pediatric echocardiography are published in a timely fashion. Concerted efforts are needed to promote trial transparency. 
546 |a EN 
690 |a clinical trial 
690 |a echocardiography 
690 |a pediatric 
690 |a ClinicalTrials.gov 
690 |a imaging 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 11 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fped.2023.1167278/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/a1ac229d819b46f791165cb032f35981  |z Connect to this object online.